# Human Beta-defensin 1 in Vitiligo

> **NCT03832751** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 25 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **OTHER:** skin biopsy before and after NB-UVB phototherapy

## Key facts

- **NCT ID:** NCT03832751
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03832751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03832751, "Human Beta-defensin 1 in Vitiligo". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03832751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*